CClinicalTrials.gg
CompletedNCT03141697Updated May 5, 2017

The Use of CO2 in Routine-Colonoscopy

An interventional study of Carbon Dioxide and Room air in Colonoscopy, sponsored by University of Leipzig. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-05-05.

Sponsored by University of Leipzig · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 5 years after the study started (first participant enrolled Apr 2012, registered Apr 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In this double-blind, randomised and controlled study 150 Patients referred to colonoscopy were assigned to either CO2 or air insufflation. We recorded basic characteristics of colonoscopy and the amount of drugs used for sedation. Patients and investigators filled out questionnaires to record pain, abdominal bloating and flatulence.

Read the detailed description

Between April 2012 and August 2014 150 patients referred to the University Hospital of Leipzig for colonoscopy were randomly assigned to either CO2 or air insufflation.

All examinations were performed by one of four experienced endoscopists. The patients usually received sedation. For sedation midazolam and propofol was used. At the beginning of the examination the patients usually received between 3-5 mg of midazolam and 20-40 mg propofol. During endoscopy propofol was titrated by administration of 20 mg at the time according to and pain reaction of the patient and required depth of sedation.

All patients had nasal insufflation of oxygen with 2 litres per minute. All sedated patients were monitored for pulse, blood pressure and blood oxygen saturation.

For bowel cleansing a solution of Macrogol 3350 (Moviprep®, Norgine) was administered orally according to the manufacturer.

All colonoscopies were performed using Fujifilm Endoscopes (EC 590 Series). For examinations with use of carbon dioxide the Fujifilm CO2 Insufflator GW-1 was used with appropriate water bottle and endoscope valve. The air pump of the light source Fujifilm System 4400 was deactivated according to the manufacturer.

02

Conditions studied

  • Colonoscopy

Keywords

  • Carbon Dioxide
  • Coloboscopy
03

In context

Lead sponsor

University of Leipzig is the lead sponsor of 147 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • older than 18 years
  • informed consent

Exclusion criteria

Exclusion Criteria:

  • former colonic resections
  • severe heart or lung disease (NYHA III or IV)
  • Pregnancy
  • Patients with planned gastroscopy within 24 hours
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
150 participants (actual)

Study arms

  • Experimental
    Carbon Dioxide

    Colonoscopy with Insufflation of Carbon Dioxide

    Device: Carbon Dioxide

  • Placebo comparator
    Room Air

    Colonoscopy with Insufflatioin of Room Air

    Device: Room air

Interventions

  • DeviceCarbon Dioxide

    Insufflation of Carbon Dioxide

  • DeviceRoom air

    Insufflation of room air

06

What researchers measure

Primary outcomes

  1. Post-procedural pain

    Pain after Colonoscopy, assessed by visual analog scale (VAS)

    Time frame: 0 - 24 hrs after colonoscopy

Secondary outcomes

  1. Abdominal bloating

    Abdominal bloating, assessed by questionaire

    Time frame: 0 - 24 hrs after colonoscopy

  2. flatulence

    flatulence, assessed by questionaire

    Time frame: 0 - 24 hrs after colonoscopy

  3. procedure time

    time used for colonoscopy

    Time frame: duration of colonoscopy

  4. Used amount of sedative drugs

    Amount of midazolam and propofol administrated during colonoscopy

    Time frame: during endoscopy

07

Study locations

1 site
  • University of Leipzig
    Leipzig, 04103, Germany
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 5, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03141697
Lead sponsor
University of Leipzig
Responsible party
Juergen Feisthammel (Medical Doctor, Principal Investigator, University of Leipzig) — Principal investigator
First posted
May 5, 2017
Start date
Apr 1, 2012
Primary completion
Aug 31, 2014
Completion
Aug 31, 2014
Last update
May 5, 2017

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion